Kingdon Capital Management »

Travere Therapeutics shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.9M 200k 29.71

More positions owned by Kingdon Capital Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
NVIDIA Corporation (NVDA)
Nexgen Energy (NXE)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Msci Sth Kor Etf (EWY)
Keysight Technologies (KEYS)
Warby Parker Cl A Com (WRBY)
Soleno Therapeutics (SLNO)
Api Group Corp Com Stk (APG)
Maplebear (CART)
Howmet Aerospace (HWM)
Ishares Tr Msci Usa Mmentm Put Option (MTUM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Everus Constr Group (ECG)

View all positions for Kingdon Capital Management

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics